萬古黴素抗藥性腸球菌感染管制措施經濟效益分析

Infection control practices for infections due to vancomycin-resistant enteroccci

10.6526/ICJ.202012_30(6).0004

郭泓頡(Hong-Jie Kuo)；劉建衛(Jien-Wei Liu)

萬古黴素抗藥性腸球菌 ； 感染控制 ； 經濟效益 ； vancomycin-resistant enterococci (VRE) ； infection prevention and control (IPAC) ； cost-effectiveness

感染控制雜誌

30卷6期（2020 / 12 / 01）

358 - 362

繁體中文

預防萬古黴素抗藥性腸球菌（vancomycin-resistant enterococci, VRE）的傳播為醫療照護機構的一個重要課題，然而對於感染管制措施的經濟效益仍然不明。本文著重回顧文獻中有關VRE感染管制措施的經濟效益分析研究。有研究指出加強VRE感控措施有正面經濟效益，且有其他研究發現中止VRE感控措施有負面經濟效益。然而有另外研究指出中止或放寬VRE感控措施並無負經濟效益。台灣未來應該加強對於VRE感控措施經濟效益分析的本土研究。

Preventing infection due to vancomycin-resistant enterococci (VRE) is a healthcare priority. However, the cost-effectiveness of VRE control interventions is unclear. This article reviewed available published studies concerning economic evaluation of VRE control practices. Some studies found implementing enhanced VRE specific control practices to be cost-effective, Others found that discontinuing VRE-specific control practices was not cost-effective, while others did not found decreasing VRE-specific control practices to be cost-effective. Further research on cost-effectiveness of infection control practices for infections due to VRE is warranted.